Biosimilar drug developer Coherus jumps into IPO pool
September 25, 2014 at 16:42 PM EDT
Biosimilar drug developer Coherus BioSciences Inc. wants to raise $86.25 million in an initial public offering...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.